Our results clearly showed that PREP inhibition reduced intestinal fibrosis in mice, demonstrating that KYP-2047 administration may contribute to preventing intestinal fibrosis and reducing ECM deposition following intestinal IRI. This evidence concerns the gene PREP and fibrosis.